Mark Enyedy
Directeur/Membre du Conseil chez ERGOMED
Postes actifs de Mark Enyedy
Sociétés | Poste | Début | Fin |
---|---|---|---|
ERGOMED | Directeur/Membre du Conseil | 10/06/2021 | - |
Independent Dir/Board Member | 10/06/2021 | - | |
BIOMARIN PHARMACEUTICAL INC. | Directeur/Membre du Conseil | 27/12/2023 | - |
Independent Dir/Board Member | 27/12/2023 | - | |
American Cancer Society New England Division, Inc. | Directeur/Membre du Conseil | - | - |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Mark Enyedy
Anciens postes connus de Mark Enyedy
Sociétés | Poste | Début | Fin |
---|---|---|---|
IMMUNOGEN, INC. | Directeur/Membre du Conseil | 16/05/2016 | 12/02/2024 |
Directeur Général | 16/05/2016 | 12/02/2024 | |
President | 16/05/2016 | 12/02/2024 | |
LOGICBIO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 17/03/2020 | 16/11/2022 |
Independent Dir/Board Member | 17/03/2020 | 16/11/2022 | |
AKEBIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/12/2018 | 02/06/2021 |
Independent Dir/Board Member | 12/12/2018 | 02/06/2021 | |
KERYX BIOPHARMACEUTICALS | Directeur/Membre du Conseil | 13/09/2017 | 12/12/2018 |
Independent Dir/Board Member | 13/09/2017 | 12/12/2018 | |
FATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2012 | 02/05/2018 |
Independent Dir/Board Member | 01/07/2012 | 02/05/2018 | |
░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Mark Enyedy
Northeastern University | Undergraduate Degree |
Harvard Law School | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 14 |
Irlande | 2 |
Royaume-Uni | 2 |
Opérationnelle
Director/Board Member | 10 |
Independent Dir/Board Member | 6 |
Corporate Officer/Principal | 3 |
Sectorielle
Health Technology | 10 |
Commercial Services | 4 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 5 |
---|---|
FATE THERAPEUTICS, INC. | Health Technology |
IMMUNOGEN, INC. | Health Technology |
AKEBIA THERAPEUTICS, INC. | Health Technology |
ERGOMED | Commercial Services |
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
Entreprise privées | 8 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Palmer & Dodge LLP | Commercial Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Keryx Biopharmaceuticals, Inc.
Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Keryx Biopharmaceuticals, Inc. engaged in the manufacture, development, and commercialization of medicines for use in treating human diseases. The company was founded in August 1, 2002 and was headquartered in Cambridge, MA. | Health Technology |
American Cancer Society New England Division, Inc. | |
LogicBio Therapeutics, Inc.
LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
- Bourse
- Insiders
- Mark Enyedy
- Expérience